Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-Rong Lai

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Bone Marrow Transplantation|August 26, 2021
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Pei-Hua Lu, De-Pei Wu, et al.
Cancer|March 23, 2023
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort studyYing-Ying Ma, Ze-Liang Wei, Ya-Jing Xu, et al.
Transplantation and Cellular Therapy|November 19, 2022
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Dao-Pei Lu, De-Pei Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2020
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled StudyYing-Jun Chang, De-Pei Wu, Yong-Rong Lai, et al.
Leukemia Research|April 1, 2015
Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in ChinaYue-Yun Lai, Xiao-Jun Huang, Juan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)Li Chen, Hong-Ming Zhu, Yan Li, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Bone Marrow Transplantation|August 26, 2021
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Pei-Hua Lu, De-Pei Wu, et al.
Cancer|March 23, 2023
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort studyYing-Ying Ma, Ze-Liang Wei, Ya-Jing Xu, et al.
Transplantation and Cellular Therapy|November 19, 2022
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Dao-Pei Lu, De-Pei Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2020
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled StudyYing-Jun Chang, De-Pei Wu, Yong-Rong Lai, et al.
Leukemia Research|April 1, 2015
Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in ChinaYue-Yun Lai, Xiao-Jun Huang, Juan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)Li Chen, Hong-Ming Zhu, Yan Li, et al.
Pageof 4